KDM5A and glioblastoma: KDM5A showed a similar higher level of mRNA expression in sarcomas (SARC) (Fig. 1A) compared to some tumors like breast-invasive carcinoma (BRCA), kidney renal clear-cell carcinoma (KIRC), glioblastoma multiforme (GBM), kidney renal papillary cell carcinoma (KIBP), brain lower-grade glioma (LGG), and ovarian serous cystadenocarcinoma (OV)18.